期刊文献+

重组α-N-乙酰半乳糖胺酶工程菌菌种稳定性研究 被引量:2

Study of heredity stability of a recombinant plasmid pET22b-a-NAGA in Escherichia coli
下载PDF
导出
摘要 目的探讨重组α-N-乙酰半乳糖胺酶工程菌菌种的遗传稳定性。方法在有选择压力(AMP+)条件下,将重组a-N-乙酰半乳糖胺酶工程菌菌株在LB固体培养基上采用划线法连续传60代,每隔20代取样保存菌种,最后同时进行菌体形态、生长速度和抗生素抗性、质粒稳定性、限制酶切图谱、测序、表达量和酶活力及Westernblotting检测。结果第0、20、40、60代菌的菌体形态、生长速度和抗生素抗性等与原代菌株无明显差异;LB固体培养基上传60代后质粒稳定性接近100%;DNA测序未见α-N-乙酰半乳糖胺酶基因变异;SDS-PAGE图谱显示,α-NAGA表达水平无明显差别。Western blotting检测显示重组α-NAGA能与抗His的单抗特异结合。结论α-N-乙酰半乳糖胺酶重组质粒pET22b-α-NAGA在工程菌株中具有良好的遗传稳定性。 Objective To investigate the heredity stability of recombinant plasmid (pET22b-a-NAGA)in host cell [ BL21 (DE3) ]. Methods Samples were collected every 20 generation. Bacteria shape, growth rate, antibiotic resistance, plasmid stability,restriction map,sequencing,expressing level,activity were analyzed. Results The passage 20^th ,40^th and 60^th Bacteria morphology, growth rate and antibiotic resistance were not evidently different from the origin ones'. The stabili- ty of the plasmid was almost 100% after 60 passages in LB solid medium. There was no variation in a-NAGA after DNA sequencing,no evident difference in a-NAGA expressing level after SDS-PAGE, and the results of Western Blotting showed that the recombinant a-NAGA can bind specifically with anti-his monoclonal antibody. Conclusion The study results indicates that the recombinant plasmid pET22b-a-NAGA has high heredity stability in BI21 (DE3) strain.
出处 《中国输血杂志》 CAS CSCD 北大核心 2011年第3期197-200,共4页 Chinese Journal of Blood Transfusion
基金 国家自然科学基金(30801063) 项目名称:A→O血型改造制备通用型红细胞 资助年限(2009.01-2011.12)
关键词 α-N-乙酰半乳糖胺酶 重组 工程菌菌种 遗传稳定性 传代 a-N-acetylgalactosaminidase Recombination Engineering bacteria strain Heredity stability Generations
  • 相关文献

参考文献6

二级参考文献13

共引文献22

同被引文献22

  • 1Wang F, Ren J, Qiu XC, et al. Selective cytotoxicity tn HER2-posi- rive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence[ J ]. Clin Cancer Res, 2010, 16 ( 8 ) : 2284 - 2294.
  • 2Ren JL, Meng YL, Hu B, et al. The effect of direct translocation across endosomes on the cytotuxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells [ J ]. Biomate- rials, 2011, 32 (30) : 7641 - 7650.
  • 3Qiu xc, Xu YM, Wang F, et al. Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth [J]. Mol Cancer Ther, 2008, 7(7) : 1890 - 1899.
  • 4Akbar S M, Hiasa Y, Mishiro S, et al. Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries [ J ]. Expert Opin Pharmacother, 2009, 10 (10) : 1605 - 1614.
  • 5Lu J J, Chen E Q, Yang J H, et al. A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients[J]. Virol J, 2012, 9:10.
  • 6Zhu Y, Qin B, Xiao C, et al. Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients[J]. Dig Dis Sci, 2012, 57:2355 -2361.
  • 7Stel' makh V V. Possibilities of using interferon-induction therapy during latent HBV infection [ J ]. Eksp Klin Farmakol, 201l, 7d :35 - 39.
  • 8Ren S, Yu H, Zhang H, et al. Polymorphisms of interferon-inducible genes OAS associated with interferon-alpha treatment response in chronic HBV infection[J]. Antiviral Res, 2011, 89:232 - 237.
  • 9Okunev O V, Gil'chuk P V, Irodov D M, et al. Production and characterization of the single chain antibodies against human alpha2b- interferon[J]. Ukr Biokhim Zh, 2005, 77(5) : 106 - 115.
  • 10Sonneveld M J, Rijckborst V, Cakaloglu Y, et al. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha2b: relation to response and HBV genotype[J]. Antivir Ther, 2012, 17:9 -17.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部